Literature DB >> 3393122

Oral challenges to detect aspirin and sulfite sensitivity in asthma.

D D Stevenson1.   

Abstract

Oral challenge with aspirin, or potential cross-reacting substances, is an effective method for establishing the presence of these sensitivities in asthmatic subjects. However, in patients with concomitant active irritable airways, testing is inaccurate and potentially dangerous. Strategies for dealing with these problems and other details important in conducting oral challenges are outlined. Sulfite challenges are conducted in a different manner and there has not been cross-sensitivity established between sulfite sensitive and aspirin sensitive asthmatics. However, many of the same problems created by heightened airway activity interfere with the accuracy of sulfite challenges. A special obstacle in interpreting the results of sulfite challenges is the issue of specificity. Oral challenges with solutions of sulfite improve sensitivity of the challenge procedure. But only low dose sulfite solutions (50 mg/ml or less) and capsules of sulfite salts are specific provoking substances for sulfite sensitivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3393122     DOI: 10.2500/108854188778995020

Source DB:  PubMed          Journal:  N Engl Reg Allergy Proc        ISSN: 0742-2814


  7 in total

1.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

Review 2.  Anaphylactic and anaphylactoid reactions to aspirin and other NSAIDs.

Authors:  Eva A Berkes
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

Review 3.  Adverse reactions to aspirin and nonsteroidal antiinflammatory drugs (NSAIDs).

Authors:  Ronald A Simon; Jennifer Namazy
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

Review 4.  Aspirin hypersensitivity and desensitization protocols: implications for cardiac patients.

Authors:  Phil Lambrakis; Gordon F Rushworth; Jane Adamson; Stephen J Leslie
Journal:  Ther Adv Drug Saf       Date:  2011-12

Review 5.  Aspirin sensitivity and desensitization for asthma and sinusitis.

Authors:  Donald D Stevenson
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

Review 6.  Aspirin and nonsteroidal anti-inflammatory drug hypersensitivity.

Authors:  James S W Kong; Suzanne S Teuber; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

Review 7.  Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.

Authors:  Ronald A Simon
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.